HSP-1-Specific Nanobodies Alter Chaperone Function in vitro and in vivo
Nicholas D. Urban, Kunal Gharat, Zachary Mattiola…·Matthias C. Truttmann
This study develops two nanobodies that specifically target HSP-1, reducing its ATPase activity and protein folding capacity both in vitro and in vivo.